| 2026-02-26 | +15.7% | earnings | Seeking Alpha | OrthoPediatrics GAAP EPS of -$0.43 misses by $0.09, revenue of $61.6M beats by $0.33M |
| 2026-02-26 | +15.7% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2025-08-05 | -13.1% | earnings | Seeking Alpha | OrthoPediatrics Non-GAAP EPS of -$0.11 beats by $0.17, revenue of $61.1M misses by $0.3M |
| 2025-08-05 | -13.1% | earnings | Seeking Alpha | OrthoPediatrics GAAP EPS of -$0.30, revenue of $61.08M |
| 2025-08-05 | -13.1% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2022-10-31 | -11.9% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2022-10-31 | -11.9% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for OrthoPediatrics (KIDS) - Zacks Investment Research |
| 2022-08-03 | +11.6% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2024-11-06 | -11.1% | earnings | Seeking Alpha | OrthoPediatrics GAAP EPS of -$0.34 misses by $0.08, revenue of $54.57M beats by $0.88M |
| 2024-11-06 | -11.1% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2025-03-04 | +10.7% | earnings | Seeking Alpha | OrthoPediatrics GAAP EPS of -$0.69 misses by $0.38, revenue of $52.7M beats by $1.54M |
| 2025-03-04 | +10.7% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2025-03-05 | +10.4% | earnings | Seeking Alpha | OrthoPediatrics Corp. 2024 Q4 - Results - Earnings Call Presentation |
| 2025-03-05 | +10.4% | earnings | Seeking Alpha | OrthoPediatrics Corp. (KIDS) Q4 2024 Earnings Call Transcript |
| 2024-11-08 | -9.7% | earnings | Seeking Alpha | OrthoPediatrics Corp. (KIDS) Q3 2024 Earnings Call Transcript |
| 2022-05-04 | -9.6% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2021-05-05 | +9.3% | legal | SEC EDGAR | KIDS 8-K: 2.02, 5.02 (SEC Filing) |
| 2026-02-27 | +8.5% | earnings | Motley Fool | OrthoPediatrics (KIDS) Q4 2025 Earnings Transcript |
| 2026-02-27 | +8.5% | earnings | Moby | OrthoPediatrics Corp. Q4 2025 Earnings Call Summary |
| 2026-02-27 | +8.5% | news | GlobeNewswire | OrthoPediatrics to Participate in Upcoming Conferences |
| 2026-02-27 | +8.5% | earnings | Seeking Alpha | OrthoPediatrics reiterates $262M–$266M 2026 revenue target as product innovation super cycle accelerates |
| 2026-02-27 | +8.5% | earnings | Seeking Alpha | OrthoPediatrics Corp. (KIDS) Q4 2025 Earnings Call Transcript |
| 2026-04-16 | -7.6% | news | GlobeNewswire | OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026 |
| 2026-04-16 | -7.6% | earnings | Stock Titan | OrthoPediatrics posts Q1 numbers April 30, call at 4:30 p.m. ET - Stock Titan |
| 2024-08-12 | -7.1% | legal | SEC EDGAR | KIDS 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2022-03-02 | -7.1% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2025-10-09 | -7.0% | earnings | Seeking Alpha | OrthoPediatrics reports preliminary Q3 revenue of $61.2M, lowers annual guidance |
| 2025-10-09 | -7.0% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2024-08-06 | -6.9% | earnings | Seeking Alpha | OrthoPediatrics Corp. (KIDS) Q2 2024 Earnings Call Transcript |
| 2025-05-07 | +6.7% | earnings | Seeking Alpha | OrthoPediatrics GAAP EPS of -$0.46 misses by $0.01, revenue of $52.4M beats by $0.72M |
| 2025-05-07 | +6.7% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2025-05-07 | +6.7% | earnings | Stock Titan | OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance - Stock Titan |
| 2021-08-04 | +6.7% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2023-05-01 | -6.3% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2023-05-01 | -6.3% | legal | SEC EDGAR | KIDS 8-K: 1.01, 2.01, 3.02, 5.02 (SEC Filing) |
| 2024-01-25 | -6.0% | news | Seeking Alpha | OrthoPediatrics cut to Hold at Truist on valuation |
| 2024-08-05 | -5.8% | news | Seeking Alpha | OrthoPediatrics announces private financing |
| 2024-08-05 | -5.8% | earnings | Seeking Alpha | OrthoPediatrics GAAP EPS of -$0.26 beats by $0.01, revenue of $52.80M beats by $0.28M |
| 2024-08-05 | -5.8% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2024-08-05 | -5.8% | legal | SEC EDGAR | KIDS 8-K: 1.01, 2.03, 3.02, 7.01, 8.01 (SEC Filing) |
| 2025-08-06 | -5.6% | earnings | Seeking Alpha | OrthoPediatrics raises 2025 revenue outlook to $237M-$242M amid accelerated OPSB clinic expansion and strong Scoliosis growth |
| 2025-08-06 | -5.6% | earnings | Seeking Alpha | OrthoPediatrics Corp. (KIDS) Q2 2025 Earnings Call Transcript |
| 2024-05-06 | +4.6% | earnings | Seeking Alpha | OrthoPediatrics Non-GAAP EPS of -$0.30 beats by $0.09, revenue of $44.7M beats by $2.93M |
| 2024-05-06 | +4.6% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2023-07-31 | -4.5% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2024-01-02 | -4.2% | legal | SEC EDGAR | KIDS 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-01-13 | -3.9% | earnings | Seeking Alpha | OrthoPediatrics reports preliminary FY 2024 net revenue of $204.7 million |
| 2025-01-13 | -3.9% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2024-03-06 | +3.9% | earnings | Seeking Alpha | OrthoPediatrics GAAP EPS of -$0.29 misses by $0.01, revenue of $37.61M misses by $0.13M |
| 2024-03-06 | +3.9% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2022-01-06 | -3.8% | legal | SEC EDGAR | KIDS 8-K: 1.01, 2.03 (SEC Filing) |
| 2022-01-10 | +3.8% | legal | SEC EDGAR | KIDS 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-11-06 | +3.7% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2026-03-03 | -3.7% | analyst | Zacks | OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock? |
| 2026-03-03 | -3.7% | analyst | Zacks | Wall Street Analysts See a 32.67% Upside in OrthoPediatrics (KIDS): Can the Stock Really Move This High? |
| 2026-03-03 | -3.7% | analyst | Yahoo Finance | OrthoPediatrics (KIDS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance |
| 2026-03-31 | +3.5% | news | GlobeNewswire | OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference |
| 2026-03-31 | +3.5% | executive | Stock Titan | OrthoPediatrics CEO and CFO join live Needham webcast on April 14 - Stock Titan |
| 2026-03-31 | +3.5% | news | GlobeNewswire | OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewswire |
| 2026-03-31 | +3.5% | legal | AD HOC NEWS | OrthoPediatrics Corp Stock: Specialized Pediatric Orthopedics Leader Faces Sector Headwinds and Grow - AD HOC NEWS |
| 2025-10-28 | -3.3% | earnings | Seeking Alpha | OrthoPediatrics Non-GAAP EPS of -$0.24 beats by $0.02, revenue of $61.2M misses by $1.07M |
| 2025-10-28 | -3.3% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2025-04-22 | -3.0% | news | Intellectia AI | KIDS Forecast — Price Prediction for 2026. Should I Buy KIDS? - Intellectia AI |
| 2025-08-11 | +2.8% | legal | SEC EDGAR | KIDS 8-K: 5.02 (SEC Filing) |
| 2022-08-12 | -2.5% | legal | SEC EDGAR | KIDS 8-K: 1.01, 8.01 (SEC Filing) |
| 2024-01-08 | -2.5% | legal | SEC EDGAR | KIDS 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-01-08 | -2.5% | legal | SEC EDGAR | KIDS 8-K: 1.01, 7.01 (SEC Filing) |
| 2024-01-08 | -2.5% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-03-07 | +2.4% | earnings | Seeking Alpha | OrthoPediatrics Corp (KIDS) Q4 2023 Earnings Call Transcript |
| 2025-05-11 | +2.3% | earnings | Seeking Alpha | OrthoPediatrics Corp. (KIDS) Q1 2025 Earnings Call Transcript |
| 2026-04-20 | -2.1% | news | Stock Titan | OrthoPediatrics (NASDAQ: KIDS) proxy details board elections and executive pay - Stock Titan |
| 2026-01-12 | +2.1% | earnings | Seeking Alpha | OrthoPediatrics sees FY25 revenue of $236.1M |
| 2026-01-12 | +2.1% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2026-01-12 | +2.1% | earnings | Quiver Quantitative | OrthoPediatrics Reports Record 2025 Revenue of $236.1 Million and Provides 2026 Financial Guidance - Quiver Quantitative |
| 2025-05-14 | -2.1% | legal | SEC EDGAR | KIDS 8-K: 1.01, 3.02 (SEC Filing) |
| 2026-03-02 | -1.8% | analyst | MT Newswires | Truist Adjusts Price Target on OrthoPediatrics to $20 From $19, Maintains Hold Rating |
| 2024-03-15 | -1.7% | legal | Seeking Alpha | OrthoPediatrics files $250M mixed securities shelf |
| 2026-03-24 | -1.7% | analyst | Zacks | Wall Street Analysts Predict a 51.12% Upside in OrthoPediatrics (KIDS): Here's What You Should Know |
| 2026-03-24 | -1.7% | analyst | Yahoo Finance | Wall Street Analysts Predict a 51.12% Upside in OrthoPediatrics (KIDS): Here's What You Should Know - Yahoo Finance |
| 2025-10-29 | -1.5% | news | Seeking Alpha | OrthoPediatrics outlines path to 12% baseline growth and free cash flow breakeven by 2026 amid clinic expansion and strong T&D momentum |
| 2025-10-29 | -1.5% | earnings | Seeking Alpha | OrthoPediatrics Corp. (KIDS) Q3 2025 Earnings Call Transcript |
| 2025-10-29 | -1.5% | news | MSN | Needham Maintains OrthoPediatrics (KIDS) Buy Recommendation - MSN |
| 2026-03-17 | -1.5% | executive | Stock Titan | OrthoPediatrics (KIDS) COO/CFO granted shares, sells stock for taxes - Stock Titan |
| 2026-04-23 | -1.5% | earnings | MarketBeat | OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat |
| 2024-05-07 | -1.4% | earnings | Seeking Alpha | OrthoPediatrics Corp. (KIDS) Q1 2024 Earnings Call Transcript |
| 2023-02-28 | +1.3% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2022-06-14 | -1.3% | legal | SEC EDGAR | KIDS 8-K: 1.01, 7.01 (SEC Filing) |
| 2025-10-10 | -1.2% | earnings | Seeking Alpha | OrthoPediatrics Corp. (KIDS) Q3 2025 Sales/Trading Call Transcript |
| 2025-10-10 | -1.2% | earnings | Benzinga | Nurix Therapeutics Posts Downbeat Q3 Results, Joins Orthopediatrics, Levi Strauss And Other Big Stocks Mo - Benzinga |
| 2021-11-04 | +1.1% | legal | SEC EDGAR | KIDS 8-K: 1.01, 5.02 (SEC Filing) |
| 2021-10-13 | +0.9% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2021-11-03 | +0.9% | legal | SEC EDGAR | KIDS 8-K: 2.02 and (SEC Filing) |
| 2023-01-09 | +0.9% | legal | SEC EDGAR | KIDS 8-K: 2.02 and 7.01 (SEC Filing) |
| 2024-10-18 | -0.7% | legal | SEC EDGAR | KIDS 8-K: 5.02 and (SEC Filing) |
| 2022-04-04 | -0.6% | legal | SEC EDGAR | KIDS 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2024-05-28 | +0.4% | legal | SEC EDGAR | KIDS 8-K: 5.02 and (SEC Filing) |
| 2022-06-15 | +0.4% | legal | SEC EDGAR | KIDS 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-04-01 | +0.4% | legal | SEC EDGAR | KIDS 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-04-01 | +0.4% | legal | Stock Titan | OrthoPediatrics (NASDAQ: KIDS) secures $20M delayed draw term loan - Stock Titan |
| 2022-10-20 | -0.3% | legal | SEC EDGAR | KIDS 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-17 | -0.3% | expansion | MarketBeat | OrthoPediatrics Details Clinic Expansion, New Launches, and 2026 Free Cash Flow Goal at Needham Conference |
| 2024-01-31 | +0.2% | analyst | eToro | KIDS Stock Price | Analyst Target 21.50 & Consensus - eToro |
| 2024-05-11 | +0.1% | earnings | MarketBeat | OrthoPediatrics (KIDS) Stock Forecast and Price Target 2026 $KIDS - MarketBeat |